Advisor Pro analyzes patient data from continuous glucose monitoring, self-monitoring blood glucose and insulin pump devices to generate personalized insulin delivery recommendations. These recommendations are meant to help healthcare providers manage treatment for patients with Type 1 diabetes.
The FDA decision marks DreaMed Diabetes’ second regulatory approval this year. The company received the European Union’s CE Mark in February.
More articles on supply chain:
4 latest FDA approvals
Almost two-thirds of consumers think product recalls are just ‘red tape’
Flex Pharma to slash 60% of workforce, consider sale or merger
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
